These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27708556)

  • 1. Precision medicine: from pharmacogenomics to pharmacoproteomics.
    Chambliss AB; Chan DW
    Clin Proteomics; 2016; 13():25. PubMed ID: 27708556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Pharmacoproteomics into Early-Phase Clinical Development: State-of-the-Art, Challenges, and Recommendations.
    Nandal S; Burt T
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational -omics: Future potential and current challenges in precision medicine.
    Wafi A; Mirnezami R
    Methods; 2018 Dec; 151():3-11. PubMed ID: 29792918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision medicine for psychopharmacology: a general introduction.
    Shin C; Han C; Pae CU; Patkar AA
    Expert Rev Neurother; 2016 Jul; 16(7):831-9. PubMed ID: 27104961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.
    Katsila T; Matsoukas MT; Patrinos GP; Kardamakis D
    OMICS; 2017 Aug; 21(8):429-439. PubMed ID: 28816643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
    Alaaeddine R; Fayad M; Nehme E; Bahmad HF; Kobeissy F
    Adv Exp Med Biol; 2017; 1007():59-70. PubMed ID: 28840552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Proteomics in the Development of Personalized Medicine.
    Jain KK
    Adv Protein Chem Struct Biol; 2016; 102():41-52. PubMed ID: 26827601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification.
    Titz B; Gadaleta RM; Lo Sasso G; Elamin A; Ekroos K; Ivanov NV; Peitsch MC; Hoeng J
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine.
    Kaddurah-Daouk R; Weinshilboum R;
    Clin Pharmacol Ther; 2015 Jul; 98(1):71-5. PubMed ID: 25871646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacometabolomics-Based Translational Biomarkers: How to Navigate the Data Ocean.
    Bafiti V; Katsila T
    OMICS; 2022 Oct; 26(10):542-551. PubMed ID: 36149303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of pharmacoproteomics in the development of personalized medicine.
    Jain KK
    Pharmacogenomics; 2004 Apr; 5(3):331-6. PubMed ID: 15102547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Metabolomics Approach to Pharmacotherapy Personalization.
    Balashova EE; Maslov DL; Lokhov PG
    J Pers Med; 2018 Sep; 8(3):. PubMed ID: 30189667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New stationary phases for enrichment and separation in the 'omics' era.
    Bakry R; Rainer M; Huck CW; Bonn GK
    Bioanalysis; 2009 Apr; 1(1):151-69. PubMed ID: 21083194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-Dependent Changes in Urinary Metabolome Before and After Intensive Phase Tuberculosis Therapy: A Pharmacometabolomics Study.
    Combrink M; du Preez I; Ronacher K; Walzl G; Loots DT
    OMICS; 2019 Nov; 23(11):560-572. PubMed ID: 31613685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic medicine on the frontier of precision medicine.
    Hasanzad M; Sarhangi N; Naghavi A; Ghavimehr E; Khatami F; Ehsani Chimeh S; Larijani B; Aghaei Meybodi HR
    J Diabetes Metab Disord; 2022 Jun; 21(1):853-861. PubMed ID: 35673457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer.
    Shukla HD
    Proteomes; 2017 Oct; 5(4):. PubMed ID: 29068423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming multiple myeloma drug resistance in the era of cancer 'omics'.
    Guang MHZ; McCann A; Bianchi G; Zhang L; Dowling P; Bazou D; O'Gorman P; Anderson KC
    Leuk Lymphoma; 2018 Mar; 59(3):542-561. PubMed ID: 28610537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex assay for multiomics advances in personalized-precision medicine.
    Popa ML; Albulescu R; Neagu M; Hinescu ME; Tanase C
    J Immunoassay Immunochem; 2019; 40(1):3-25. PubMed ID: 30632882
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.